Title: Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
13224-94-7
14048-30-7
14687-15-1
14168-65-1
16232-91-0
1825-00-9
7620-77-1 | Lithium 12-hydroxystearate | AA00G66J | MFCD00067252
1159803-65-2 | 2-(3-3,5-Dichlorophenyl)-2,3-dihydro-1h-naphtho[1,8-de][1,3,2]diazaborinine | AA00HD2H | MFCD20527130
1427502-92-8 | 2-Bromo-3-fluoro-6-nitrotoluene | AA00HWJQ | MFCD23704111
3962-66-1 | Estr-5(10)-ene-3,17-dione | AA00I7PP | MFCD00271641
895134-29-9 | 3-Benzyloxy-6-(tert-butyl-dimethylsilanyloxymethyl)-4-oxo-4h-pyran-2-carboxylic acid | AA00IFOD | MFCD26959170
1290541-38-6 | 3-ethynyloxetane | AA00ILBI | MFCD26516293
179627-11-3 | 3-[4-(methylcarbamoyl)phenyl]prop-2-enoic acid | AA019L5N | MFCD06797692
799835-40-8 | 3-Iodo-1-methyl-1H-pyrazole-4-carboxylic acid | AA01B2B6 | MFCD28142291
724711-21-1 | 2-(2-(Quinolin-3-yl)pyridin-4-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one | AA01CBHB | MFCD16293712
96036-02-1 | Meropenem p-nitrobenzyl diester | AA01DQ5G | MFCD08703333
